Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | APAF1 | O14727 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.58 |
| ▸ | FDPS | P14324 | 17/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL582395 | 0.92 | MEN1 (0.63) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Sulfuric Acid SCHEMBL27783819 | 0.91 | MEN1 (0.61) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Sulfuric Acid SCHEMBL2993814 | 0.89 | MEN1 (0.67) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Sulfuric Acid SCHEMBL28980890 | 0.89 | MEN1 (0.67) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Sulfuric Acid SCHEMBL27783818 | 0.89 | MEN1 (0.67) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Sulfuric Acid SCHEMBL28130835 | 0.89 | MEN1 (0.67) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Sulfuric Acid SCHEMBL28449063 | 0.89 | MEN1 (0.67) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Sulfuric Acid SCHEMBL28653447 | 0.88 | MEN1 (0.71) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5285827 | 0.88 | MEN1 (0.65) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL294165 | 0.88 | MEN1 (0.65) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100239524-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | NOVARTIS AG (CH) | 2010-09-23 | — | — | US | claimed |
| US-20060147532-A1 | Microparticles prepared using an ionic liquid | AUSBORN MICHAEL | 2006-07-06 | — | — | US | claimed |
| EP-1569621-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | Novartis AG (CH) | 2005-09-07 | — | — | EP | claimed |
| WO-2004052340-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | NOVARTIS AG (CH) | 2004-06-24 | — | — | WO | claimed |
| EP-2593403-B1 | METHOD FOR PRODUCING A GEL FILM AND FILTRATION MEMBRANE PREPARED WITH THIS METHOD | UNIV MONASH (AU) | 2020-03-04 | — | — | EP | disclosed |
| US-10297396-B2 | Graphene-based films | MONASH UNIVERSITY (AU) | 2019-05-21 | — | — | US | disclosed |
| US-9751763-B2 | Material and applications therefor | MONASH UNIVERSITY (AU) | 2017-09-05 | — | — | US | disclosed |
| US-20160016804-A1 | GRAPHENE-BASED FILMS | MONASH UNIVERSITY (AU) | 2016-01-21 | — | — | US | disclosed |
| US-20130180912-A1 | MATERIAL AND APPLICATIONS THEREFOR | MONASH UNIVERSITY (AU) | 2013-07-18 | — | — | US | disclosed |
| US-8276664-B2 | Well treatment operations using spherical cellulosic particulates | BAKER HUGHES INCORPORATED (US) | 2012-10-02 | — | — | US | disclosed |
| US-20120220775-A1 | ENANTIOSELECTIVE PREPARATION OF QUINOLINE DERIVATIVES | LOHSE OLIVIER (FR) | 2012-08-30 | — | — | US | disclosed |
| US-20100239524-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | NOVARTIS AG (CH) | 2010-09-23 | — | — | US | disclosed |
| US-7605267-B2 | Process for the preparation of 5-(halocetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones | NOVARTIS AG (CH) | 2009-10-20 | — | — | US | disclosed |
| US-20090044942-A1 | Cellulosic Particulates and Method of Manufacture and Use Thereof | BJ SERVICES COMPANY | 2009-02-19 | — | — | US | disclosed |
| US-20060189653-A1 | Process for the preparation of 5-(halocetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones | NOVARTIS AG (CH) | 2006-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100239524-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | FIBP, MIF, CHMP4B | MEN1 1303/4885HSP90AA1 2183/4885KMT2A 4402/4885 |
| US-20120220775-A1 | ENANTIOSELECTIVE PREPARATION OF QUINOLINE DERIVATIVES | OPRM1, OPRD1, HAX1 | MEN1 3029/4885HSP90AA1 2920/4885KMT2A 279/4885 |
| US-20060189653-A1 | Process for the preparation of 5-(halocetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones | UGT8, KAT8, UGT1A8 | MEN1 3671/4885HSP90AA1 470/4885KMT2A 418/4885 |
| US-20060147532-A1 | Microparticles prepared using an ionic liquid | FIBP, MIF, CHMP4B | MEN1 1303/4885HSP90AA1 2183/4885KMT2A 4402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.